Quanterix Corp Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts

martes, 3 de marzo de 2026, 12:30 am ET1 min de lectura
QTRX--

Quanterix Corp reported Q4 2025 revenue of $43.9 million, a 25% YoY increase and 7% sequential growth. However, organic revenue declined by 22% YoY. The company's spatial revenue decreased by 23% YoY, and pharma revenue declined by 21% YoY. Despite this, Quanterix achieved significant milestones with its Lucent AD complete test and launched 13 new assays in 2025. The company is on track to achieve $85 million in cost synergies and reach cash flow breakeven in the second half of 2026.

Quanterix Corp Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios